HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xavier Filella Selected Research

Proteins (Proteins, Gene)

7/2013Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.
11/2011Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
12/2010Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance.
4/2007Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size.
1/2004Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xavier Filella Research Topics

Disease

23Neoplasms (Cancer)
01/2020 - 05/2003
17Prostatic Neoplasms (Prostate Cancer)
02/2020 - 06/2004
7Lung Neoplasms (Lung Cancer)
02/2016 - 01/2004
7Multiple Myeloma
01/2014 - 05/2004
6Infections
05/2021 - 08/2002
5Adenocarcinoma
06/2012 - 05/2005
5Renal Insufficiency (Renal Failure)
04/2012 - 01/2004
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2016 - 05/2003
4Pathologic Complete Response
01/2014 - 12/2009
4Disease Progression
07/2013 - 01/2003
4Breast Neoplasms (Breast Cancer)
01/2012 - 01/2003
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2009 - 01/2004
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2009 - 01/2004
3Premature Obstetric Labor (Premature Labor)
01/2021 - 05/2009
3Necrosis
01/2020 - 03/2008
3Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2017 - 01/2004
3Liver Diseases (Liver Disease)
04/2012 - 01/2008
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2005 - 11/2002
2Sepsis (Septicemia)
05/2021 - 03/2008
2Inflammation (Inflammations)
01/2021 - 10/2010
2Colorectal Neoplasms (Colorectal Cancer)
09/2014 - 12/2013
2Jaundice (Icterus)
06/2012 - 04/2012
2Pneumonia (Pneumonitis)
01/2012 - 04/2004
2Myocardial Infarction
12/2008 - 11/2002
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
03/2008 - 01/2007
2Carcinoma (Carcinomatosis)
05/2005 - 05/2003
2Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2005 - 05/2003
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2005 - 06/2004
2Fever (Fevers)
08/2004 - 02/2002
2Plasmacytoma
07/2004 - 05/2004
1Infertility (Sterility)
05/2021
1Cardiogenic Shock
02/2020
1Encephalitis (Encephalitis, Rasmussen)
01/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2020
1Osteoporosis
01/2020
1Fibrosis (Cirrhosis)
01/2019
1Hepatorenal Syndrome
01/2019
1Secondary Hyperparathyroidism
01/2019
1Hypocalcemia
01/2019
1Acute Kidney Injury (Acute Renal Failure)
01/2019
1Osteitis Deformans (Paget's Disease of Bone)
01/2019
1Circulating Neoplastic Cells
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
03/2017
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2017

Drug/Important Bio-Agent (IBA)

18Tumor Biomarkers (Tumor Markers)IBA
02/2020 - 01/2002
17Interleukin-6 (Interleukin 6)IBA
01/2021 - 02/2002
15Biomarkers (Surrogate Marker)IBA
10/2019 - 08/2003
10Prostate-Specific Antigen (Semenogelase)IBA
02/2020 - 06/2004
7CytokinesIBA
01/2020 - 08/2002
6Carcinoembryonic AntigenIBA
02/2016 - 05/2003
6antigen CYFRA21.1IBA
10/2011 - 01/2005
5pro-gastrin-releasing peptide (31-98)IBA
03/2017 - 01/2004
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 02/2002
5AntigensIBA
02/2016 - 01/2007
5Peptides (Polypeptides)IBA
02/2016 - 07/2004
5big gastrinIBA
02/2016 - 07/2004
5Proteins (Proteins, Gene)FDA Link
07/2013 - 01/2004
4MicroRNAs (MicroRNA)IBA
10/2019 - 05/2017
3InterleukinsIBA
01/2020 - 11/2002
3Phosphopyruvate Hydratase (Enolase)IBA
02/2016 - 10/2011
3CarbohydratesIBA
02/2016 - 07/2010
3Keratin-19 (Keratin 19)IBA
02/2016 - 01/2005
3Hemoglobins (Hemoglobin)IBA
09/2014 - 02/2002
3Anti-Bacterial Agents (Antibiotics)IBA
08/2004 - 01/2004
2Interleukin-10 (Interleukin 10)IBA
01/2020 - 11/2002
2C-Reactive ProteinIBA
01/2020 - 03/2008
2GlucocorticoidsIBA
01/2020 - 02/2003
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 02/2002
2Kallikreins (Kallikrein)IBA
01/2018 - 06/2015
2NF-kappa B (NF-kB)IBA
04/2013 - 09/2006
2Docetaxel (Taxotere)FDA Link
04/2013 - 09/2006
2Immunoglobulins (Immunoglobulin)IBA
07/2012 - 01/2011
2Oncogene Proteins (Oncogene Protein)IBA
01/2012 - 06/2010
2Oligoclonal BandsIBA
01/2011 - 12/2009
2Estrogen ReceptorsIBA
07/2010 - 06/2010
2Thalidomide (Thalomid)FDA Link
07/2004 - 05/2004
2CreatinineIBA
01/2004 - 01/2004
2Interleukin-8 (Interleukin 8)IBA
01/2004 - 11/2002
1SolutionsIBA
05/2021
1Rituximab (Mabthera)FDA Link
01/2020
1etelcalcetide hydrochlorideIBA
01/2019
1PeriostinIBA
01/2019
1Tartrate-Resistant Acid PhosphataseIBA
01/2019
1Lipocalin-2IBA
01/2019
1Cinacalcet (Sensipar)FDA Link
01/2019
1CalciumIBA
01/2019
1Androgen Receptors (Androgen Receptor)IBA
01/2018
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
03/2017
1Tyrosine Kinase InhibitorsIBA
03/2017
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2017
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2014

Therapy/Procedure

6Therapeutics
01/2011 - 02/2002
4Stem Cell Transplantation
01/2014 - 08/2004
2Renal Dialysis (Hemodialysis)
01/2019 - 01/2004
2Transplantation
07/2013 - 07/2012
2Hematopoietic Stem Cell Transplantation
07/2012 - 12/2009
1Catheters
05/2021
1Length of Stay
02/2020
1Intravenous Administration
01/2019